An experimental compound appears to improve stroke outcomes by reducing lingering inflammation, leading to better memory and movement in its aftermath. The compound, known as compound 21, stimulates the angiotensin type 2 receptor, which aids blood vessel dilation, minimizes cell death, and reduces inflammation.
Researchers are investigating the impact of antioxidant vitamins C and E, alpha lipoic acid, resveratrol, and Sirt1 on blood vessel health in premenopausal women with type 1 diabetes. Early evidence suggests that treatment may restore protection against cardiovascular disease.
Scientists investigate TRPV1 receptor, found in immune cells, as potential target for TBI recovery. Activating TRPV1 may balance macrophage populations and promote M2s, reducing lingering inflammation and improving cognition.
Diabetes impairs autophagy, a protective mechanism that filters blood waste, worsening prognosis and destroying kidneys. Researchers focus on restoring autophagy to find new therapies for acute kidney injury.
Researchers discovered mouse genes that enhance human T-cell power against liver cancer, offering new hope for patients. Engineered human T cells eradicated cancer without harming normal liver tissue.
A single high-fat milkshake can quickly transform healthy red blood cells into small, spiky cells that wreak havoc inside blood vessels. This study found that such a meal can lead to impaired ability of blood vessels to relax and an immune response similar to one provoked by an infection.
A new clinical trial combines two immunotherapies, PD-1 antibody and poly-IC, to enhance T-cell response against solid tumors. The treatment aims to improve patient outcomes for a wide range of cancers, including lung, liver, colon, and others.
A newly designed chimera could simultaneously decrease the expression of three growth factors that are over-expressed in some cancers, leading to cancer cell death. The molecule has potent anti-tumor activity and is non-toxic, simple to produce, and cost-effective compared to traditional treatment strategies.
Scientists found that a small daily dose of Viagra significantly reduces colorectal cancer risk in genetically predisposed animal models. The drug works by increasing levels of cyclic GMP, which suppresses excessive cell proliferation and promotes normal cell differentiation.
Researchers are exploring how obesity impacts cardiovascular health in premenopausal women, a population with heightened risk due to estrogen levels and hormone sensitivity. They aim to understand the underlying mechanisms and identify potential treatments to restore protection against cardiovascular disease.
Research analysis of blood mediators in type 1 diabetes and kidney disease patients reveals 10 elevated proteins, with TNF-alpha family and IL-6 significantly impacting 40% of patients. This study suggests personalized medicine approach to target specific inflammatory mediators for effective treatment.
Researchers found that antibiotics can hinder the efficacy of some cancer treatments, particularly adoptive T-cell therapy, by impacting the gut microbiota. However, CAR T-cell therapy appears to be less affected by antibiotic use.
Researchers have identified two distinct types of vision-degrading glaucoma and pinpointed key genes associated with the condition. The study also suggests that exercise can help reduce eye pressure and provides a potential new point of intervention for treating glaucoma.
A portable ultrasound helps nephrologists detect fluid in the lungs of patients with end-stage kidney disease, allowing for more targeted dialysis treatments. This technology could save around $21 million annually by reducing ER dialysis costs and unnecessary hospitalizations.
Researchers discover a possible direct connection between disrupted circadian clocks and increased levels of ADAM17, an enzyme that promotes inflammation and stiffens blood vessel walls. This relationship could explain why poor sleep habits contribute to cardiovascular disease risk factors.
Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells. The new Luminex Multiplex Glycan Array enables rapid analysis of patient samples and glycans, potentially leading to early disease detection and diagnosis.
Researchers discover that low levels of microRNA miR-125a-5p correlate with high levels of protein TIMP-1 in human lung cancer cells. Increasing miR-125a-5p levels reduces cancer spread and increases cell death. TIMP-1's role is also explored, revealing its dual function in promoting or inhibiting tumor growth.
Dr. Alexis M. Stranahan's study suggests that an apple-shaped physique, characterized by fat depositing around the abdominal cavity, may be worse for the brain than previously thought. Conversely, subcutaneous fat under the skin appears to protect the brain from cognitive decline.
Researchers have found that blocking production of the chemical 20-HETE can control glioblastoma and breast cancer growth. The inhibitor HET0016 reduced tumor aggressiveness and invasiveness, slowing disease progression.
Researchers identified six novel chromosomal regions associated with type 1 diabetes, enabling the discovery of more genes that cause the disease. The study also found different genetic markers for early detection of autoantibodies in patients at risk.
Researchers have identified a key gene, Ufbp1, that helps maintain healthy Paneth cells in the small intestine, which are essential for a balanced gut microbiome. The study found that when this gene is knocked out, Paneth cells die and good bacteria levels decrease, leading to inflammatory bowel disease.
A study found that high doses of vitamin D significantly reduced arterial stiffness in a population with vitamin deficiency. The results suggest that vitamin D supplementation can be an effective treatment for improving cardiovascular health.
In diabetes, copper excess hinders angiogenesis, leading to impaired blood flow and increased risks of heart attacks and nerve death. Researchers are exploring ATP7A's therapeutic potential to restore healthy copper balance and improve vascular repair functions.
Scientists discover that pain medicine pentazocine preserves vision in a model of severe retinal degeneration by activating the Nrf2-Keap1 antioxidant pathway. The drug normalizes Nrf2 levels, potentially restoring its protective function and preventing oxidative stress.
A decade-long study on hundreds of HPV vaccine recipients found the vaccine to be safe and effective in preventing the most virulent strains of the virus. The quadrivalent vaccine was virtually 100% effective in preventing disease in young individuals.
Researchers found that patients with high levels of indoleamine 2,3 dioxygenase (IDO) at diagnosis have lower overall survival rates and early mortality. IDO expression should routinely be measured during bone marrow biopsies to identify potential treatment targets.
A national cooperative group trial is making a handful of experts in rare leukemia available around the clock to reduce high mortality rates. The goal is to decrease induction mortality from 30% to 6.7% by providing timely management and care for patients with acute promyelocytic leukemia.
Researchers are investigating a novel treatment approach for Parkinson's disease by inhibiting the protein Bach1, which blocks the body's natural protection against oxidative stress. By removing Bach1, scientists aim to restore balance and promote the activation of neuroprotective genes.
A large NIH-funded clinical trial will determine if bone marrow transplantation can be part of standard care for patients with severe sickle cell disease. The study aims to balance health risks with the promise of being cured, and participants will be followed for two years.
Scientists identify protein disulfide isomerase (PDI) as a key therapeutic target to improve blood vessel health in diabetes. PDI regulates angiogenesis, wound healing and mitochondrial function, offering new potential treatments.
Scientists are learning how too little body fat damages the cardiovascular system, similar to obesity. Leptin replacement therapy shows promise in reducing cardiovascular risk and improving metabolic function in individuals with congenital lipodystrophy and other conditions.
Researchers have identified adenosine receptor A2a as a potential target for reducing dysfunctional blood vessel development in the eye. Blocking this receptor has been shown to inhibit pathological angiogenesis and promote healthy blood vessel formation, offering new hope for treating diabetic retinopathy.
A recent study published in The Journal of Nutrition found that adolescents consuming the least amount of vitamin K1 were at a higher risk for unhealthy enlargement of their heart's major pumping chamber. This association was independent of other factors such as physical activity and blood pressure.
Researchers found two types of T cells respond differently to cancer antigens, with one starting strong but exhausting quickly and the other staying on target for a longer antitumor effect. The study suggests that targeting the persistent T cell type could lead to more effective cancer vaccines.
Researchers found that intermittent electrical stimulation improved working memory in adult non-human primates, whereas continuous deep brain stimulation impaired memory. The study suggests that increased acetylcholine levels and blood flow may contribute to the benefits of intermittent stimulation.
Researchers found that a synthetic peptide called TIP strengthens the barrier function of lung capillaries, preventing fluid accumulation and potential deadly complications. The study suggests a promising strategy for reducing dangerous fluid volume in lungs, particularly for vulnerable populations like children under five.
Researchers found that osteocytes, tiny bone cells with delicate membranes, experience membrane tears in response to mechanical loading. This tear triggers an increase in calcium levels, leading to bone remodeling and strengthening. The discovery sheds light on how bones adapt to gravity and physical activity.
Dr. Betty S. Pace will receive the ASH Leadership in Promoting Diversity Award for her commitment to diversity and inclusion in hematology. She has trained over 80 underrepresented minority individuals, including 45% of those she has personally mentored.
Dr. Richard McIndoe receives $12.8 million grant to continue leading a national research initiative focused on diabetic complications, including nerve and kidney damage, high blood pressure, cardiovascular disease, and stroke. The consortium supports short-term studies and summer programs for medical students.
Research suggests sugary drinks can lead to leptin resistance in rats, causing them to overeat and gain weight. This phenomenon may also apply to humans, highlighting the potential dangers of frequent sugary drink consumption.
Researchers found that ECT had no specific anti-insomnia effect on older patients with depression. In fact, their insomnia problems persisted despite treatment improvements in non-insomnia symptoms. The study suggests that ECT may not be a reliable option for addressing sleep issues in this population.
After stem cell therapy, tests like SPEP/SIFE and SFLCA may yield oligoclonal patterns that resemble the original monoclonal antibody spike. However, this is a normal response to treatment, not recurrence of the disease. The key clarifier lies in tracking the location of the malignant spike before and after treatment.
Researchers hope IBM's Watson will help people with cancer by providing detailed information on genetic mutations and targeted therapies. With Watson, pathologists can analyze multiple genes simultaneously, including those that are not currently tested, to provide more personalized care to patients.
Researchers suggest targeting aldosterone receptor for effective hypertension treatment in women. High aldosterone levels are linked to increased blood pressure and cardiovascular risk.
Researchers found manmade peptides significantly reduce metastasis in a mouse model of aggressive breast cancer. These peptides directly disrupt the WASF3 gene, which helps cancer cells move and invade other tissues.
Vitamin D deficiency may impair corneal healing in individuals with underlying health issues, such as diabetes. Research suggests that vitamin D plays a role in cell communication and connectivity, which is essential for proper wound healing.
Researchers have discovered that inhibiting 20-HETE, an acid metabolite overexpressed in cancer cells, reduces breast cancer tumor size and ability to spread. The study found that the drug HET0016 blocks key pathways that enable cancer cells to create a distant microenvironment.
A study found that age and obesity create a perfect storm that damages the tiny blood vessels that directly feed the heart muscle, leading to reduced blood flow and increased risk of heart failure. The inflammation caused by both factors thickens the walls of these microvasculature, making them less able to dilate and sustain the heart.
Studies found significant differences in microRNA cargo carried by exosomes in males and females with osteoarthritis, with females showing more altered biological processes. The findings suggest a link between estrogen levels and the development of osteoarthritis, potentially leading to new diagnostic and treatment options.
Scientists have found that pericytes, strong contractile cells forming blood vessels, can also produce tumors and enable their spread. GT198, a gene normally expressing stem-cell like properties, becomes an oncogene when mutated, promoting cancer growth.